Copper dyshomeostasis and cardiovascular disease: Molecular mechanisms and new strategies for targeted intervention with cuproptosis (Review)
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5690 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Peiyu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Aff…. Hauptthemen laut MEDLINE: Copper, Homeostasis, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide and their pathological mechanisms have remained a major focus of research. Notably, copper has an essential role in maintaining cardiovascular homeostasis and disruption of copper metabolism can lead to a range of pathological consequences. The present review summarizes the dynamic balance of copper metabolism, clarifies its regulatory network encompassing intestinal absorption, intracellular transport, tissue storage and excretion, and emphasizes the molecular associations between copper dyshomeostasis and CVDs, including atherosclerosis and stroke. Notably, cuproptosis, a newly identified mode of regulated cell death, provides novel insights into the role of copper‑induced cell death in the cardiovascular system. Based on current research progress, the current review also discusses the value of therapeutics that target copper metabolism, such as copper chelators, ionophores and dietary interventions. Furthermore, key unanswered questions are identified, particularly those regarding the specific molecular pathways linking copper homeostasis to cardiovascular function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong 250014, P.R. China.
- Department of Cardiovascular Surgery, Institute of Chronic Diseases, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong 266021, P.R. China.
Zitieren
APA
Li, P., Li, Y., Meng, Q., Wang, J., Wang, K., & Yang, S. (2025). Copper dyshomeostasis and cardiovascular disease: Molecular mechanisms and new strategies for targeted intervention with cuproptosis (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5690
Vancouver
Li P, Li Y, Meng Q, Wang J, Wang K, Yang S. Copper dyshomeostasis and cardiovascular disease: Molecular mechanisms and new strategies for targeted intervention with cuproptosis (Review). International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5690
BibTeX
@article{Li2025,
author = {Li, Peiyu and Li, Yinghui and Meng, Qian and Wang, Jie and Wang, Kun and Yang, Sumin},
title = {Copper dyshomeostasis and cardiovascular disease: Molecular mechanisms and new strategies for targeted intervention with cuproptosis (Review)},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5690}
}
EUVIMED